G. Tallini et al., DETECTION OF THYROGLOBULIN, THYROID PEROXIDASE, AND RET PTC1 MESSENGER-RNA TRANSCRIPTS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH THYROID-DISEASE/, Journal of clinical oncology, 16(3), 1998, pp. 1158-1166
Purpose: Detection of mRNA transcripts for thyroglobulin (TG), thyroid
peroxidase (TPO) and RET/PTC1 in the peripheral blood of patients wit
h thyroid disease. Patients and Methods: TG, TPO, and RET/PTC1 mRNA we
re analyzed in 52 peripheral-blood samples from 44 patients diagnosed
with thyroid carcinoma (24 patients), adenoma (five patients), and nod
ular hyperplasia (15 patients) by reverse transcription-polymerase cha
in reaction (RT-PCR). Results: TG and TPO were identified in 13 patien
ts (54.2%) with thyroid carcinoma, which includes five of eight patien
ts with no clinical evidence of disease at the time of blood collectio
n. Four of 5 patients had cervical lymph node metastases and/or extrat
hyroid extension at the rime of the initial surgery. RET/PTC1 mRNA was
detected in the peripheral blood of only one patient with papillary t
hyroid carcinoma, This sample was also positive for TG and TPO. TG and
TPO were detected in two patients (10%) with benign thyroid nodules,
All positive samples from patients with benign thyroid lesions were co
llected before surgery, whereas all samples collected after surgery we
re negative, RET/PTC1 mRNA was not detected in any of the patients wit
h benign thyroid nodules, RT-PCR positivity for TG and TPO mRNA was hi
gher in patients with carcinoma than in patients with benign lesions (
P = .002). Conclusion: TG, TPO, and RET/PTC1 mRNA are detectable in th
e peripheral blood of patients with thyroid disease, which correlates
with a diagnosis of carcinoma. (C) 1998 by American Society of Clinica
l Oncology.